Is there a role for thioguanine therapy in IBD in 2017 and beyond?
- 20 February 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 11 (5) , 473-486
Abstract
Introduction: Conventional thiopurines are effective for the maintenance of remission of Crohn’s disease and ulcerative colitis, however, up to half of patients are intolerant or unresponsive to these medications. Thioguanine is an alternative thiopurine that has shown efficacy in inflammatory bowel disease, and is particularly useful to circumvent certain side effects associated with conventional thiopurines, for example, pancreatitis. Its association with nodular regenerative hyperplasia of the liver has hindered its widespread use. Areas covered: We aim to outline the rational use of thioguanine, including safety monitoring, with particular regard to hepatotoxicity. A literature search was performed: PubMed was searched for full papers and abstracts published in English since January 2000 using the following terms, alone and in combination: ‘azathioprine’, ‘thiopurine’, ‘Crohn’s disease’, ‘inflammatory bowel disease’, ‘nodular regenerative hyperplasia’, ‘mercaptopurine’, ‘thioguanine’, ‘ulcerative colitis’. Further relevant papers were identified from the reference lists of selected papers. Expert commentary: Despite optimisation strategies such as metabolite measurements and the use of allopurinol, a significant proportion of patients will remain intolerant to thiopurines, especially those with allergic reactions, including pancreatitis. For this subgroup of patients we suggest that low dose thioguanine is an alternative to other therapies that are either parenteral or expensive.Keywords
This publication has 74 references indexed in Scilit:
- Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel DiseaseAmerican Journal of Epidemiology, 2013
- Tioguanine in the treatment of refractory coeliac disease – a single centre experienceAlimentary Pharmacology & Therapeutics, 2012
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancerNature Reviews Cancer, 2008
- Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBDNature Clinical Practice Gastroenterology & Hepatology, 2007
- Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprineGut, 2007
- Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel DiseaseClinical Pharmacokinetics, 2001
- Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patientsJournal of Hepatology, 1991
- The purine path to chemotherapyBioscience Reports, 1989
- ACUTE LEUKAEMIA DURING PREGNANCYThe Lancet, 1987